Tuberculosis, Renal
Showing 1 - 25 of >10,000
Latent Tuberculosis, End Stage Renal Disease, Renal Transplant Candidate for Right Kidney Trial in New Brunswick (Rifapentine)
Not yet recruiting
- Latent Tuberculosis
- +3 more
-
New Brunswick, New JerseyPinki J Bhatt
Jun 6, 2022
DS Titanium Ligation Clip in Urology
Completed
- Prostate Cancer
- +7 more
-
Offenburg, GermanyOrtenau Klinikum Klinik für Urologie und Kinderurologie
Apr 11, 2022
Latent Tuberculosis, Kidney Failure Trial (Rifampicin plus Isoniazid, Rifapentine plus Isoniazid, Rifampicin alone)
Not yet recruiting
- Latent Tuberculosis
- Kidney Failure
- Rifampicin plus Isoniazid
- +2 more
- (no location specified)
Aug 24, 2021
HaemoDYNAMICs in Primary and Secondary Hypertension
Recruiting
- Primary Hypertension
- +3 more
- Nitroglycerin 0.25 mg (single dose, no longer given since January 2017)
- +5 more
-
Tampere, Southern Finland, Finland
- +1 more
Aug 12, 2021
Pulmonology Trial in Taipei (Rifamycin-containing regimen, Rifamycin-free regimen)
Recruiting
- Pulmonology
- Rifamycin-containing regimen
- Rifamycin-free regimen
-
Taipei, TaiwanNational Taiwan University Hospital
Oct 18, 2022
Tuberculosis, Pulmonary Trial in Houston (Azacitidine Injection)
Not yet recruiting
- Tuberculosis, Pulmonary
- Azacitidine Injection
-
Houston, TexasHarris Health System - Ben Taub Hospital
Sep 1, 2022
Tuberculosis Trial in Singapore (Doxycycline, Placebo)
Not yet recruiting
- Tuberculosis
- Doxycycline
- Placebo
-
Singapore, SingaporeNational University Hospital
Jul 21, 2022
Plasma Concentration of Linezolid Antibiotic and Treatment
Recruiting
- Myelosuppression
- +2 more
-
Taipei, Test2, TaiwanNational Taiwan University Hospital
Feb 8, 2022
Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Not yet recruiting
- Covid-19 Pandemics
- Tuberculosis
- Pfizer-BioNTech COVID-19 vaccine
- +2 more
-
Mae Sot, Tak, ThailandShoklo Malaria Research Unit (SMRU)
Oct 21, 2022
Improving HIV/Tuberculosis Outcomes in Irkutsk
Completed
- Tuberculosis
- +2 more
-
Irkutsk, Russian FederationIrkutsk Regional Clinical Tuberculosis Hospital
Mar 8, 2022
Tuberculosis, Latent Tuberculosis, Tuberculosis Prevention Trial in Kampala (CRP, point-of-care assay)
Recruiting
- Tuberculosis
- +3 more
- CRP, point-of-care assay
-
Kampala, UgandaKampala Capital City Authority Clinic
Apr 21, 2022
Epstein-Barr Virus Infection moniToring in renAl Transplant
Recruiting
- EBV Infection
- +3 more
- EBV DNA in whole blood and plasma
-
Aarhus, Central Region Denmark, Denmark
- +2 more
Dec 12, 2022
Hospitalized Pulmonary Tuberculosis at Strasbourg University
Recruiting
- Pulmonary Tuberculosis
-
Strasbourg, FranceCentre de Ressources et de Compétences de la Mucoviscidose (CRCM
Oct 25, 2023
Tuberculosis, HIV Trial in Worldwide (Rifapentine (RPT), Isoniazid (INH), Pyridoxine (Vitamin B6))
Completed
- Tuberculosis
- HIV Infections
- Rifapentine (RPT)
- +2 more
-
La Jolla, California
- +44 more
Nov 2, 2021
HIV Infected Population With Latent Tuberculosis Trial run by the CC (rifapentene (RPT), darunavir/cobicistat (DRV/c), Isoniazid
Completed
- HIV Infected Population With Latent Tuberculosis
- rifapentene (RPT)
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 15, 2022
Tuberculosis Trial in Worldwide (rifapentine, rifapentine and moxifloxacin, control)
Tuberculosis Trial in Ogre, Siauliai, Vilnius (Delamanid, Optimized Background Regimen (OBR))
Terminated
- Tuberculosis
- Delamanid
- Optimized Background Regimen (OBR)
-
Ogre, Latvia
- +2 more
Oct 14, 2021
Tuberculosis, Post-Tuberculous Pleural Fibrosis, Post-Tuberculous Bronchiectasis Trial in Peshawar (Experimental, Control)
Recruiting
- Tuberculosis
- +2 more
- Experimental
- Control
-
Peshawar, KPK, PakistanGreen Star NGO
Sep 14, 2023
Tuberculosis, Latent Tuberculosis Infection Trial in Bijie, Linping, Qingzhen (QuantiFERON-TB Gold (QFT) test)
Recruiting
- Tuberculosis
- Latent Tuberculosis Infection
- QuantiFERON-TB Gold (QFT) test
-
Bijie, Guizhou, China
- +4 more
Sep 12, 2023
Drug Resistant Tuberculosis Trial (Nurse-Led Treatment in Primary Care)
Not yet recruiting
- Drug Resistant Tuberculosis
- Nurse-Led Treatment in Primary Care
- (no location specified)
Dec 20, 2022
KAP Regarding Tuberculosis Among Physicians in Assiut City
Not yet recruiting
- Tuberculosis
- (no location specified)
Apr 6, 2023
Tuberculosis Trial in Shanghai, Hangzhou (Short-course regimen, Standard regimen)
Active, not recruiting
- Tuberculosis
- Short-course regimen
- Standard regimen
-
Shanghai, Shanghai, China
- +1 more
Nov 22, 2023
Clinical Trial Trial in Moshi (Evaluation of high dose rifampicin in children)
Recruiting
- Clinical Trial
- Evaluation of high dose rifampicin in children
-
Moshi, Kilimanjaro, Tanzania
- +1 more
Sep 13, 2021
Sensitivity and Specificity of Xpert MTB/RIF Ultra
Not yet recruiting
- Tuberculosis
- (no location specified)
Oct 1, 2023
COPD Trial (previous pulmonary tuberculosis)
Not yet recruiting
- COPD
- previous pulmonary tuberculosis
- (no location specified)
Oct 5, 2023